Lijing XinLijing Xin is a research staff scientist and 7T MR Operational Manager at the Center for Biomedical Imaging (CIBM), Ecole polytechnique fédérale de Lausanne (EPFL), Switzerland. Her research interests focus on developing cutting-edge magnetic resonance spectroscopy and imaging methods for better understanding the brain function and the pathophysiology of neurological diseases. Her journey on magnetic resonance imaging (MRI) started from her master project during 2002-2005, where she developed a gradient unit with eddy current compensation and a pulse sequence generator for MRI spectrometer, which enhanced her knowledge in MR instrumentation. Later, she obtained her PhD in physics from Ecole polytechnique fédérale de Lausanne (EPFL) in 2010, where she focused on developing various novel 1H and 13C magnetic resonance spectroscopy (MRS) acquisition and quantification methods as well as RF coils on high field preclinical MR scanners. Afterwards, she started working on the clinical MR platforms including both 3 and 7T and continued to improve and develop novel acquisition and quantification methods for 1H, 13C and 31P nuclei. She carries on interdisciplinary collaborations with different partners, particularly with clinical partners where translational strategies are performed to explore the pathophysiology of psychiatric disorders and disease biomarkers for early diagnose and intervention.
Katarzyna PierzchalaKatarzyna Pierzchala completed professional studies at the Faculty of Physics at University of Silesia and at the Medical University of Silesia, Poland. She obtained her BSc degree (2003) and MSc degree (2005) in Medical Physics from the University of Silesia, Poland. In 2010 she obtained her PhD degree in physics (biomedical physics) “Oxidative Stress on Human Cells in the Presence of Nano-Sized Titanium Dioxide” from the Swiss Federal Institute of Technology at Lausanne (EPFL), Institute of Physics of Complex Matter, Switzerland. In 2013, she joined, as a Scientist, the Laboratory for Functional and Metabolic Imaging at EPFL, where she implemented the electron paramagnetic resonance spectroscopy (EPR) and optical and fluorescence microscopy to study the brain redox and antioxidant state in rodent models of human diseases ie. hepatic encephalopathy and the magnetic resonance spectroscopy (MRS) of intact living cancerous cells to characterize their metabolic profile and metastatic potential and observe changes of MRS signals intensity associated to cells metabolism after in vitro chemotherapy to provide better understanding of the mechanisms of drug-cell interaction, with a view to offer appropriate treatment.